| Jeffrey Davis, PHARMD | |
|
105 Mall Blvd, Monroeville, PA 15146-2213 | |
| (800) 238-7828 | |
| Not Available |
| Full Name | Jeffrey Davis |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 105 Mall Blvd, Monroeville, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043866544 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP443575 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Davis, PHARMD 105 Mall Blvd, Monroeville, PA 15146-2213 Ph: () - | Jeffrey Davis, PHARMD 105 Mall Blvd, Monroeville, PA 15146-2213 Ph: (800) 238-7828 |
News Archive
Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).
Medication used to treat patients with type II diabetes activates sensors on brain cells that increase hunger, causing people taking this drug to gain more body fat, according to researchers at Georgia State University, Oregon Health and Science University, Georgia Regents University and Charlie Norwood Veterans Administration Medical Center.
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
Problems walking including slow gait and a short stride are associated with an increased risk of cognitive decline, Mayo Clinic researchers have discovered. Their findings are being presented at the Alzheimer's Association International Conference July 14-19 in Vancouver, British Columbia.
Researchers at the Shiley-Marcos Alzheimer's Disease Research Center at the University of California San Diego are about to launch a Phase 2 clinical trial to test a gene therapy treatment for Alzheimer's disease (AD) called CERE-110.
› Verified 3 days ago
Mr. Mark Durigon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Mall Blvd, Monroeville, PA 15146 Phone: 800-238-7828 | |
Philip Depietro, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Mall Blvd, Monroeville, PA 15146 Phone: 800-238-7828 | |
Julie Kent, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Mall Blvd, Monroeville, PA 15146 Phone: 800-238-7828 Fax: 888-772-3244 | |
Sherry Zelno, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Mall Blvd, Monroeville, PA 15146 Phone: 800-238-7828 | |
Jacquelyn Alicia Mowry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Mall Blvd, Monroeville, PA 15146 Phone: 800-238-7828 | |
Shannon Hunsberger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Mall Blvd, Monroeville, PA 15146 Phone: 800-238-7828 | |
Brian Taylor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Mall Blvd, Monroeville, PA 15146 Phone: 800-283-7828 |